MilliporeSigma, 14920 Broschart Road, Rockville, MD, 20850, USA.
Sci Rep. 2021 Dec 8;11(1):23600. doi: 10.1038/s41598-021-03160-8.
Sensitive detection of off-target sites produced by gene editing nucleases is crucial for developing reliable gene therapy platforms. Although several biochemical assays for the characterization of nuclease off-target effects have been recently published, significant technical and methodological issues still remain. Of note, existing methods rely on PCR amplification, tagging, and affinity purification which can introduce bias, contaminants, sample loss through handling, etc. Here we describe a sensitive, PCR-free next-generation sequencing method (RGEN-seq) for unbiased detection of double-stranded breaks generated by RNA-guided CRISPR-Cas9 endonuclease. Through use of novel sequencing adapters, the RGEN-Seq method saves time, simplifies workflow, and removes genomic coverage bias and gaps associated with PCR and/or other enrichment procedures. RGEN-seq is fully compatible with existing off-target detection software; moreover, the unbiased nature of RGEN-seq offers a robust foundation for relating assigned DNA cleavage scores to propensity for off-target mutations in cells. A detailed comparison of RGEN-seq with other off-target detection methods is provided using a previously characterized set of guide RNAs.
基因编辑核酸酶产生的脱靶位点的敏感检测对于开发可靠的基因治疗平台至关重要。尽管最近已经发表了几种用于描述核酸酶脱靶效应的生化分析方法,但仍存在重大的技术和方法学问题。值得注意的是,现有的方法依赖于 PCR 扩增、标记和亲和纯化,这可能会引入偏差、污染物、通过处理导致的样品损失等。在这里,我们描述了一种灵敏、无 PCR 的下一代测序方法(RGEN-seq),用于无偏检测 RNA 引导的 CRISPR-Cas9 内切酶产生的双链断裂。通过使用新型测序接头,RGEN-Seq 方法节省了时间,简化了工作流程,并消除了与 PCR 和/或其他富集步骤相关的基因组覆盖偏差和缺口。RGEN-seq 与现有的脱靶检测软件完全兼容;此外,RGEN-seq 的无偏性质为将分配的 DNA 切割分数与细胞中脱靶突变的倾向联系起来提供了坚实的基础。使用先前表征的一组指导 RNA 对 RGEN-seq 与其他脱靶检测方法进行了详细比较。